Related Experiment Video
Updated: May 2, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells
Gabriel Brisou1, Delphine Manzoni, Stephane Dalle
1Laboratoire d'Hématologie Cellulaire, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
Hematology analyzers can help detect Sezary syndrome by flagging abnormal lymphocytes. Specific parameters like LyX and LyZ, along with the Blast/Abn Lympho alarm, correlate with Sezary cell presence and prognosis.
Area of Science:
- Hematology
- Clinical Cytology
- Oncology
Background:
- Cytological review of circulating neoplastic cells is crucial for diagnosis and prognosis.
- Manual or automated microscopic analysis requires expert cytologists.
- Hematology analyzer parameters can alert operators to potential abnormalities.
Purpose of the Study:
- To evaluate the utility of hematology analyzer parameters in detecting Sezary syndrome.
- To correlate specific analyzer parameters with Sezary cell characteristics and prognosis.
Main Methods:
- Blood samples from Sezary syndrome patients (n=9) were analyzed using a Sysmex XN-1000 analyzer.
- Control groups included patients with benign/tumoral skin lesions (n=47) and chronic lymphoproliferative B-cell diseases (n=51).
Main Results:
- Structural lymphoid parameters (LyX, LyZ) and the Blast/Abn Lympho alarm were significantly higher in Sezary cases versus controls.
- LyX values correlated with the count of circulating Sezary cells.
- LyZ values correlated with the presence of large Sezary cells, both identified as prognostic factors.
Conclusions:
- The combination of Blast/Abn Lympho alarm and structural parameters (Ly-X/Ly-Z/Ly-Y) can help establish rules for blood slide review.
- This approach shows promise for screening circulating Sezary cells, particularly in B-cell diseases.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014